Laboratory Forecast, price target & analysts
Laboratory Target price 2026 - Analyst rating & recommendation
Laboratory Classifications & Recommendation
Laboratory Price Target
| Target Price | $357.00 |
| Price | $309.57 |
| Potential |
15.32%
register free of charge
|
| Number of Estimates | 20 |
|
20 Analysts have issued a price target Laboratory 2027 .
The average Laboratory target price is $357.00.
This is
15.32%
register free of charge
$404.25
30.58%
register free of charge
$297.61
3.86%
register free of charge
|
|
| A rating was issued by 27 analysts: 21 Analysts recommend Laboratory to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Laboratory stock has an average upside potential 2027 of
15.32%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 13.95 | 15.19 |
| 7.25% | 8.88% | |
| EBITDA Margin | 12.87% | 17.79% |
| 20.11% | 38.18% | |
| Net Margin | 6.28% | 10.07% |
| 9.55% | 60.29% |
22 Analysts have issued a sales forecast Laboratory 2026 . The average Laboratory sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Laboratory EBITDA forecast 2026. The average Laboratory EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
23 Laboratory Analysts have issued a net profit forecast 2026. The average Laboratory net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 10.46 | 18.91 |
| 18.33% | 80.78% | |
| P/E | 16.37 | |
| EV/Sales | 2.03 |
23 Analysts have issued a Laboratory forecast for earnings per share. The average Laboratory EPS is
This results in the following potential growth metrics and future valuations:
Current Laboratory Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jul 31 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
